| 000 | 01870 a2200601 4500 | ||
|---|---|---|---|
| 005 | 20250517164620.0 | ||
| 264 | 0 | _c20180601 | |
| 008 | 201806s 0 0 eng d | ||
| 022 | _a1476-5551 | ||
| 024 | 7 |
_a10.1038/leu.2017.221 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAl-Sawaf, O | |
| 245 | 0 | 0 |
_aImpact of gender on outcome after chemoimmunotherapy in patients with chronic lymphocytic leukemia: a meta-analysis by the German CLL study group. _h[electronic resource] |
| 260 |
_bLeukemia _c10 2017 |
||
| 300 |
_a2251-2253 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aClinical Trials, Phase II as Topic |
| 650 | 0 | 4 | _aClinical Trials, Phase III as Topic |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGender Identity |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunotherapy _xmethods |
| 650 | 0 | 4 |
_aLeukemia, Lymphocytic, Chronic, B-Cell _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aRobrecht, S | |
| 700 | 1 | _aBahlo, J | |
| 700 | 1 | _aFink, A M | |
| 700 | 1 | _aCramer, P | |
| 700 | 1 | _avon Tresckow, J | |
| 700 | 1 | _aMaurer, C | |
| 700 | 1 | _aBergmann, M | |
| 700 | 1 | _aSeiler, T | |
| 700 | 1 | _aLange, E | |
| 700 | 1 | _aKneba, M | |
| 700 | 1 | _aStilgenbauer, S | |
| 700 | 1 | _aDöhner, H | |
| 700 | 1 | _aKiehl, M G | |
| 700 | 1 | _aJäger, U | |
| 700 | 1 | _aWendtner, C M | |
| 700 | 1 | _aFischer, K | |
| 700 | 1 | _aGoede, V | |
| 700 | 1 | _aHallek, M | |
| 700 | 1 | _aEichhorst, B | |
| 700 | 1 | _aHopfinger, G | |
| 773 | 0 |
_tLeukemia _gvol. 31 _gno. 10 _gp. 2251-2253 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/leu.2017.221 _zAvailable from publisher's website |
| 999 |
_c27404145 _d27404145 |
||